MedTrace Logo

Obstructive Sleep Apnea & Covid-19 Outcomes

NCT04363333 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 320

Last updated 2021-02-17

No results posted yet for this study

Summary

Covid-19 infection is an on-going pandemic with worse diagnosis in adults with comorbid conditions such as hypertension and cardiopulmonary diseases. Obstructive sleep apnea (OSA) is common in those comorbidities and may contribute to worse prognosis for the Covid-19 cases.

Conditions

Interventions

DIAGNOSTIC_TEST

Home Sleep Apnea Testing or In-hospital Polysomnography

Home Sleep Apnea Testing or In-hospital Polysomnography will be conducted 4 to 6 months after the Covid-19 diagnosis

Sponsors & Collaborators

  • Koc Healthcare Istanbul American Hospital, Marmara University Hospital

    collaborator UNKNOWN

  • Koç University

    lead OTHER

Principal Investigators

  • Yuksel Peker, MD, PhD · Koc University School of Medicine

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-27
Primary Completion
2021-05-31
Completion
2021-07-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04363333 on ClinicalTrials.gov